NLRP3 and Alzheimer disease: Additionally, recent evidence suggests that miRNAs play a crucial role in regulating NLRP3 expression as well, implying that epigenetic interventions could offer therapeutic options to manage the inflammasome-mediated neuroinflammation in AD (Heneka et al. 2018; He et al. 2025; Swanson et al. 2019).